Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

Akdis D, Brunckhorst C, Duru F, Saguner AM.

Arrhythm Electrophysiol Rev. 2016 Aug;5(2):90-101. doi: 10.15420/AER.2016.4.3.

2.

Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.

Brinkmeyer-Langford C, Balog-Alvarez C, Cai JJ, Davis BW, Kornegay JN.

BMC Genomics. 2016 Aug 22;17:665. doi: 10.1186/s12864-016-2948-z.

3.

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling.

Bayzigitov DR, Medvedev SP, Dementyeva EV, Bayramova SA, Pokushalov EA, Karaskov AM, Zakian SM.

Cardiol Res Pract. 2016;2016:3582380. doi: 10.1155/2016/3582380. Epub 2016 Mar 27. Review.

4.

Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes.

Dubash AD, Kam CY, Aguado BA, Patel DM, Delmar M, Shea LD, Green KJ.

J Cell Biol. 2016 Feb 15;212(4):425-38. doi: 10.1083/jcb.201507018. Epub 2016 Feb 8.

5.

Erosion of Conserved Binding Sites in Personal Genomes Points to Medical Histories.

Guturu H, Chinchali S, Clarke SL, Bejerano G.

PLoS Comput Biol. 2016 Feb 4;12(2):e1004711. doi: 10.1371/journal.pcbi.1004711. eCollection 2016 Feb.

6.

Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.

Tanaka A, Yuasa S, Node K, Fukuda K.

Int J Mol Sci. 2015 Aug 12;16(8):18894-922. doi: 10.3390/ijms160818894. Review.

7.

Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.

Kamdar F, Klaassen Kamdar A, Koyano-Nakagawa N, Garry MG, Garry DJ.

J Card Fail. 2015 Sep;21(9):761-70. doi: 10.1016/j.cardfail.2015.04.010. Epub 2015 Apr 28. Review.

8.

Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.

Hemnes AR, Trammell AW, Archer SL, Rich S, Yu C, Nian H, Penner N, Funke M, Wheeler L, Robbins IM, Austin ED, Newman JH, West J.

Circulation. 2015 Jan 27;131(4):401-9; discussion 409. doi: 10.1161/CIRCULATIONAHA.114.013317. Epub 2014 Oct 31.

9.

Arrhythmogenic right ventricular dysplasia back in force.

Fontaine G, Chen HS.

Am J Cardiol. 2014 May 15;113(10):1735-9. doi: 10.1016/j.amjcard.2014.03.001. Epub 2014 Mar 14. No abstract available.

10.

Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease.

Saguner AM, Brunckhorst C, Duru F.

World J Cardiol. 2014 Apr 26;6(4):154-74. doi: 10.4330/wjc.v6.i4.154. Review.

11.

Science and practice of arrhythmogenic cardiomyopathy: A paradigm shift.

Elmaghawry M, Migliore F, Mohammed N, Sanoudou D, Alhashemi M.

Glob Cardiol Sci Pract. 2013 Nov 1;2013(1):63-79. doi: 10.5339/gcsp.2013.8. eCollection 2013. Review. No abstract available.

12.

Human-induced pluripotent stem cell models of inherited cardiomyopathies.

Karakikes I, Termglinchan V, Wu JC.

Curr Opin Cardiol. 2014 May;29(3):214-9. doi: 10.1097/HCO.0000000000000049. Review.

13.

Desmosomal cadherins are decreased in explanted arrhythmogenic right ventricular dysplasia/cardiomyopathy patient hearts.

Vite A, Gandjbakhch E, Prost C, Fressart V, Fouret P, Neyroud N, Gary F, Donal E, Varnous S, Fontaine G, Fornes P, Hidden-Lucet F, Komajda M, Charron P, Villard E.

PLoS One. 2013 Sep 23;8(9):e75082. doi: 10.1371/journal.pone.0075082. eCollection 2013.

14.

Hinged plakin domains provide specialized degrees of articulation in envoplakin, periplakin and desmoplakin.

Al-Jassar C, Bernadό P, Chidgey M, Overduin M.

PLoS One. 2013 Jul 29;8(7):e69767. doi: 10.1371/journal.pone.0069767. Print 2013.

15.

Quantitative Immunohistochemistry of Desmosomal Proteins (Plakoglobin, Desmoplakin and Plakophilin), Connexin-43, and N-cadherin in Arrhythmogenic Cardiomyopathy: An Autopsy Study.

Tavora F, Zhang M, Cresswell N, Li L, Fowler D, Franco M, Burke A.

Open Cardiovasc Med J. 2013 Mar 29;7:28-35. doi: 10.2174/1874192401307010028. Print 2013.

16.

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch D, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Cogan JD, Mason WR, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Smith K, McKean D, Pedersen BS, Talbert J, Kidd RN, Markin CR, Beckman KB, Lathrop M, Schwarz MI, Schwartz DA.

Nat Genet. 2013 Jun;45(6):613-20. doi: 10.1038/ng.2609. Epub 2013 Apr 14. Erratum in: Nat Genet. 2013 Nov;45(11):1409.

17.

Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.

Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, Kan NG, Forcales S, Puri PL, Leone TC, Marine JE, Calkins H, Kelly DP, Judge DP, Chen HS.

Nature. 2013 Feb 7;494(7435):105-10. doi: 10.1038/nature11799. Epub 2013 Jan 27.

18.

Beyond cell adhesion: the role of armadillo proteins in the heart.

Swope D, Li J, Radice GL.

Cell Signal. 2013 Jan;25(1):93-100. doi: 10.1016/j.cellsig.2012.09.025. Epub 2012 Sep 27. Review.

19.

Plakophilin-3 is required for late embryonic amphibian development, exhibiting roles in ectodermal and neural tissues.

Munoz WA, Kloc M, Cho K, Lee M, Hofmann I, Sater A, Vleminckx K, McCrea PD.

PLoS One. 2012;7(4):e34342. doi: 10.1371/journal.pone.0034342. Epub 2012 Apr 5.

20.

Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathy.

Rajkumar R, Sembrat JC, McDonough B, Seidman CE, Ahmad F.

BMC Med Genet. 2012 Mar 29;13:21. doi: 10.1186/1471-2350-13-21.

Items per page

Supplemental Content

Write to the Help Desk